Free Trial

Belluscura (BELL) Competitors

GBX 2.20 +0.18 (+8.64%)
As of 02/21/2025 10:47 AM Eastern

BELL vs. IHC, MHC, AVO, RUA, SUN, DEMG, SN, MXCT, NIOX, and EKF

Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Inspiration Healthcare Group (IHC), MyHealthChecked (MHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), Smith & Nephew (SN), MaxCyte (MXCT), NIOX Group (NIOX), and EKF Diagnostics (EKF). These companies are all part of the "medical devices" industry.

Belluscura vs.

Inspiration Healthcare Group (LON:IHC) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability.

In the previous week, Inspiration Healthcare Group had 1 more articles in the media than Belluscura. MarketBeat recorded 1 mentions for Inspiration Healthcare Group and 0 mentions for Belluscura. Inspiration Healthcare Group's average media sentiment score of 0.30 beat Belluscura's score of 0.00 indicating that Inspiration Healthcare Group is being referred to more favorably in the media.

Company Overall Sentiment
Inspiration Healthcare Group Neutral
Belluscura Neutral

Inspiration Healthcare Group has higher revenue and earnings than Belluscura. Inspiration Healthcare Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspiration Healthcare Group£42.87M0.40-£12.20M-£14.58-1.36
Belluscura£2.87M1.93-£29.55M-£9.37-0.23

Inspiration Healthcare Group received 103 more outperform votes than Belluscura when rated by MarketBeat users.

CompanyUnderperformOutperform
Inspiration Healthcare GroupOutperform Votes
103
68.21%
Underperform Votes
48
31.79%
BelluscuraN/AN/A

46.1% of Inspiration Healthcare Group shares are held by institutional investors. Comparatively, 6.3% of Belluscura shares are held by institutional investors. 31.8% of Inspiration Healthcare Group shares are held by insiders. Comparatively, 56.3% of Belluscura shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Inspiration Healthcare Group has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.

Inspiration Healthcare Group has a net margin of -28.46% compared to Belluscura's net margin of -1,030.73%. Inspiration Healthcare Group's return on equity of -34.30% beat Belluscura's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspiration Healthcare Group-28.46% -34.30% -3.47%
Belluscura -1,030.73%-102.62%-43.53%

Summary

Inspiration Healthcare Group beats Belluscura on 9 of the 14 factors compared between the two stocks.

Get Belluscura News Delivered to You Automatically

Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BELL vs. The Competition

MetricBelluscuraMedical Devices IndustryMedical SectorLON Exchange
Market Cap£5.55M£3.34B£5.84B£2.64B
Dividend YieldN/A2.42%4.75%4.98%
P/E Ratio-0.2368.8926.38162.45
Price / Sales1.93147.36435.33313,812.36
Price / Cash8.0015.3838.0128.15
Price / Book0.194.287.645.16
Net Income-£29.55M£116.55M£3.19B£5.75B
7 Day Performance-2.14%-0.09%-2.12%-1.02%
1 Month Performance-75.34%-1.84%-0.44%-0.86%
1 Year Performance-90.83%13.02%16.30%39.56%

Belluscura Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BELL
Belluscura
N/AGBX 2.20
+8.6%
N/A-90.0%£5.55M£2.87M-0.2324Gap Down
IHC
Inspiration Healthcare Group
N/AGBX 14.06
-1.3%
N/A-44.0%£12.61M£34.30M-100.42224Gap Up
High Trading Volume
MHC
MyHealthChecked
N/AGBX 19
+2.7%
N/A+25.0%£9.88M£9.39M-950.0016Gap Up
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 13.29
+2.2%
N/A+24.5%£8.25M£2.19M-332.2548
SUN
Surgical Innovations Group
N/AGBX 0.62
+12.4%
N/A-11.5%£5.77M£12.54M-21.1180Gap Up
DEMG
Deltex Medical Group
N/AGBX 0.03
-6.1%
N/A-92.9%£589,000.00£1.78M-5.7537Gap Down
SN
Smith & Nephew
3.7285 of 5 stars
GBX 1,009.50
+0.5%
GBX 4,607.50
+356.4%
-9.6%£8.80B£5.64B3,738.8918,452High Trading Volume
MXCT
MaxCyte
N/AGBX 342.50
+0.7%
N/A-12.5%£359.93M£45.44M-1,317.3180
NIOX
NIOX Group
N/AGBX 61.49
-2.4%
N/A+6.4%£260.79M£39M3,074.4092News Coverage
Gap Up
EKF
EKF Diagnostics
N/AGBX 24.79
-0.1%
N/A-21.2%£112.46M£50.95M2,478.50356News Coverage
Negative News
Gap Down

Related Companies and Tools


This page (LON:BELL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners